Phase | Phase 1 Mar–Jun 2020 |
---|---|
Observed mean LoS, days | 9.048 |
Unadjusted counterfactuala mean LoS, days | 9.010 |
Implied excess days per infection (95% CI) | 1.9 (1.7, 2.1) |
Counterfactuala mean LoS, adjusted for confounding, days | 9.007 |
Implied excess days per infection (95% CI) | 2.0 (1.8, 2.2) |